After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.19B. A total of 2.95 million shares were traded on the day, compared to an average of 1.44M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, AUPH has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Greenleaf Peter sold 195,593 shares of AUPH for 8.00 per share on Mar 03 ’25. After the transaction, the Chief Executive Officer now owns 1,953,892 company shares. In a previous transaction on Mar 04 ’25, Greenleaf Peter sold 164,947 shares at 7.92 per share. AUPH shares that Chief Executive Officer owns now total 1,788,945.
Among the insiders who sold shares, Keenan Greg disposed of 12,239 shares on Mar 03 ’25 at a per-share price of $8.00. This resulted in the Chief Medical Officer holding 161,789 shares of AUPH after the transaction. In another insider transaction, Miller Joseph M sold 61,859 shares at $8.00 per share on Mar 03 ’25. Company shares held by the Chief Financial Officer now total 633,515.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for AUPH in the last 3 months, the mean price target is $9.83 with high estimates of $12.00 and low estimates of $8.00. In terms of 52-week highs and lows, AUPH has a high of $10.67 and a low of $4.71.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.68, while its Total Shareholder’s Equity was $479.09M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.43.
